RBC Europe’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-115
| Closed | -$11K | – | 947 |
|
|
2021
Q3 | $11K | Hold |
115
| – | – | ﹤0.01% | 917 |
|
|
2021
Q2 | $11.2K | Sell |
115
-75
| -39% | -$7.3K | ﹤0.01% | 931 |
|
|
2021
Q1 | $18.5K | Hold |
190
| – | – | ﹤0.01% | 786 |
|
|
2020
Q4 | $18.2K | Buy |
190
+115
| +153% | +$11K | ﹤0.01% | 743 |
|
|
2020
Q3 | $7.21K | Hold |
75
| – | – | ﹤0.01% | 858 |
|
|
2020
Q2 | $9.15K | Hold |
75
| – | – | ﹤0.01% | 785 |
|
|
2020
Q1 | $6.49K | Hold |
75
| – | – | ﹤0.01% | 788 |
|
|
2019
Q4 | $8.06K | Hold |
75
| – | – | ﹤0.01% | 837 |
|
|
2019
Q3 | $6.76K | Hold |
75
| – | – | ﹤0.01% | 856 |
|
|
2019
Q2 | $6.33K | Hold |
75
| – | – | ﹤0.01% | 884 |
|
|
2019
Q1 | $6.61K | Hold |
75
| – | – | ﹤0.01% | 895 |
|
|
2018
Q4 | $5.36K | Hold |
75
| – | – | ﹤0.01% | 915 |
|
|
2018
Q3 | $9.22K | Hold |
75
| – | – | ﹤0.01% | 868 |
|
|
2018
Q2 | $7.37K | Hold |
75
| – | – | ﹤0.01% | 907 |
|
|
2018
Q1 | $6.22K | Buy |
+75
| New | +$6.22K | ﹤0.01% | 917 |
|